Does a reduced 11 beta HSD type 2 activity contribute to sodium retention in the nephrotic syndrome?
Kerstens
Michiel N
MN
Navis
Gerjan
G
Dullaart
Robin P F
RP
D042842:11-beta-Hydroxysteroid Dehydrogenases; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000097:blood; D003345:Corticosterone / Q000097:blood; D004195:Disease Models, Animal; D006801:Humans; D006913:Hydroxysteroid Dehydrogenases / Q000652:urine*; D009404:Nephrotic Syndrome / Q000097:blood / Q000201:enzymology* / Q000652:urine*; D011237:Predictive Value of Tests; D051381:Rats; D014883:Water-Electrolyte Imbalance / Q000097:blood / Q000201:enzymology* / Q000652:urine*
D000893:Anti-Inflammatory Agents; D006913:Hydroxysteroid Dehydrogenases; D042842:11-beta-Hydroxysteroid Dehydrogenases; D003345:Corticosterone